Compare Immunefi (IMU) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunefi vs Enzyme — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 5× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Enzyme for 29 Days on average.
| IMU | MLN | |
|---|---|---|
Market Cap | Rp27,03M | Rp134,13M |
Volume (24h) | Rp39,91M | Rp104,56M |
Circulating Supply | 873,4M / 10B IMU (9%) | 3,3M MLN |
Typical Hold Time | 5 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IMU token shows limited market activity with a modest market cap of Rp27.03M and only 9% circulating supply. The token exhibits low trading volume and minimal network activity, with a short average hold time of 5 days indicating speculative trading patterns. Recent coverage appears to confuse this cryptocurrency with a corporate entity, creating market confusion.
Outlook remains cautious due to extremely low liquidity and market confusion with traditional equity. Key risk is entity misidentification impacting proper valuation. Opportunity exists if protocol utility develops, but current fundamentals are weak with minimal ecosystem activity.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
